Anti-Neoplastic Agents Market

  • Published on 2025-11-11
  • Report Code: 588
  • 170-350 pages
Anti-Neoplastic Agents Market

Anti-Neoplastic Agents Market By Product Type (Chemotherapeutic agents, Biological/immunotherapeutic agent, Personalized medicine and Others); By Cancer Type (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/lung Cancer and Other); By End User (Hospitals, Clinics, Research Institutes, Cancer Rehabilitation Centers and Others); and Region - Global Analysis of Market Size, Share & Trends for 2019- 2020 and Forecasts to 2030

Table Of Content

Contents          

  1. Executive Summary
  2. Global Anti-Neoplastic Agents Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Anti-Neoplastic Agents Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Anti-Neoplastic Agents Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Volume (Billion Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12. Global Anti-Neoplastic Agents Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. By Product Type: Market Share (2019-2030F)
      1. Chemotherapeutic agents, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Biological/immunotherapeutic agent, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Personalized medicine, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Others, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    3. By Cancer Type: Market Share (2019-2030F)
      1. Blood cancer, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Breast cancer, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Gastrointestinal cancer, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Prostate cancer, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Respiratory/lung cancer, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      6. Others, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    4. By End User: Market Share (2019-2030F)
      1. Hospitals, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Clinics, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Research Institutes, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Cancer Rehabilitation Centers, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Others, By Value (USD Billion) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

Company Profile

  1. Hoffmann-La Roche
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis   
    7. Product Launch
  2. Amgen Inc.
  3. Bristol-Myers Squibb Company
  4. Baxter Healthcare Corporation
  5. Boehringer Ingelheim GmbH
  6. Aspen Global Inc.
  7. Bayer AG
  8. Teva pharmaceutical Industries Ltd.
  9. Johnson & Johnson Pvt. Ltd.
  10. Merc & Co.
  11. Pfize Inc.,
  12. Accord Healthcare, Inc.
  13. Genentech, Inc.
  14. Lundbeck LLC
  15. AbbVie Inc.
  16. Other Prominent Players

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients